Beta Bionics, Inc./$BBNX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Beta Bionics, Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

Ticker

$BBNX
Sector
Primary listing

Employees

390

BBNX Metrics

BasicAdvanced
$954M
-
-$3.35
-
-

Bulls say / Bears say

Entered a strategic partnership with Abbott to integrate the iLet Bionic Pancreas with Abbott’s future dual glucose-ketone sensor, enhancing device functionality and strengthening competitive differentiation (Nasdaq)
Secured effective formulary agreements with all major pharmacy benefit managers as of July 1, 2025, reducing patient cost barriers and expected to accelerate iLet adoption under pharmacy benefits (Nasdaq)
Achieved a Relative Strength Rating of 83, surpassing the 80-point market-leadership threshold, alongside a reported 54% sales increase, reflecting strong investor interest and growth momentum (Investor’s Business Daily)
Net loss widened to $28.7 million, or 162% of sales, in Q1 2025 compared with $12.4 million a year earlier, underscoring continued unprofitability (Beta Bionics IR)
Gross margin fell to 50.9% in Q1 2025 from 55.7% in Q1 2024, a 482 bp drop that signals rising cost pressures and margin squeeze (Beta Bionics IR)
Despite 54% sales growth, Beta Bionics reported zero percent EPS growth in the latest quarter, highlighting persistent financial leverage and bottom-line challenges (Investor’s Business Daily)
Data summarised monthly by Lightyear AI. Last updated on 7 Oct 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $BBNX

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs